What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

UNC Center for AIDS Research

Home
United States
Chapel Hill, NC
UNC Center for AIDS Research

A research center with a fierce commitment to creating and translating knowledge that advances the f

03/26/2026

The Office of AIDS Research (OAR) in collaboration with NIH Institutes and Offices has announced the dates for their upcoming Office Hours for ECIs in HIV Research:

-Friday, March 27 (1pm-4pm ET); Register by 5pm ET on Thursday, March 26.
-Monday, April 6 (2pm-4pm ET); Register by 5pm ET on Sunday, April 5.
-Wednesday, April 8 (2pm-4pm ET); Register by 5pm ET on Tuesday, April 7.
-Friday, April 10 (1pm-4pm ET); Register by 5pm ET on Thursday April 9.

These 30-minute one-on-one (1:1) appointments with NIH Program Officers (PO) are reserved exclusively for ECIs who intend to submit an application in 2026.

Find out more and register here: https://www.med.unc.edu/cfar/2026/03/nih-office-hours-for-early-career-investigators/

03/19/2026

The 2026 application cycle for the HIV, Infectious Disease and Global Health Implementation Research Institute (HIGH IRI) is now open! Hosted by Washington University in St. Louis, HIGH IRI is a prestigious two-year mentored training program that equips scholars with the latest methods in dissemination & implementation (D&I) research specifically tailored to infectious diseases and global health challenges.

Applications are open until March 31, 2026 at 5 PM CST.

Read more here: https://www.med.unc.edu/cfar/2026/03/call-for-applicants-2026-high-iri-implementation-research-training/

03/12/2026

Cindy Gay, MD, MPH, David Margolis, MD, and the UNC HIV Cure Center have launched two ambitious studies that are poised to advance HIV Cure science closer to ending the epidemic. The first uses highly engineered antibody-like molecules to help the immune system find and clear HIV‑infected cells, uniting UNC with research partners in Kenya and the U.S. Military HIV Research Program. The second, is testing a brand‑new drug (IAP 086) with a novel mechanism designed to awaken the hidden HIV reservoir.

Read more here: https://globalhealth.unc.edu/2026/03/gay-leads-new-frontiers-in-hiv-cure-science/

03/06/2026

The Leadership of the National Institute of Allergy and Infectious Disease (NIAD) recently published a comment in the Nature titled: “The new vision from the National Institute of Allergy and Infectious Diseases (NIAID).” In the article, NIAID leadership introduced two new strategic aims: (1) Support research to address important challenges in infectious diseases that affect Americans and (2) Support research addressing key problems in immunology and allergic and autoimmune disorders affecting Americans.

Read more here: https://tinyurl.com/3n76nrb6

02/26/2026

Join us for the March CFAR-Wide Webinar, "Advancing the Mission: Future Directions for NIH HIV Research," with Dr. Geri Donenberg, the Associate Director for AIDS Research and Director of the Office of AIDS Research (OAR) at the National Institutes of Health (NIH). The webinar will be on March 23rd from 3:30-4:30 pm ET via Zoom. Learn more and register here: https://tinyurl.com/y48h4m88

02/12/2026

Early registration for AIDS 2026 ends today, February 12. The Conference will take place July 26-31, 2026 in Rio de Janeiro, Brazil and virtually. This year’s theme will be Rethink. Rebuild. Rise. At a pivotal moment for HIV research and response—marked by unprecedented funding cuts and disruptions to HIV programs—the world’s largest HIV/AIDS conference will convene people living with HIV, researchers, policymakers, healthcare professionals, funders, media, and community representatives.

Learn more about early registration here: https://tinyurl.com/2v75aan4

Read more about the conference here: https://tinyurl.com/2jrwk6em

02/05/2026

Join the UNC CFAR and the NIH in honoring National Black HIV/AIDS Awareness Day on February 7th! Since 1999, this day has highlighted the importance of community engagement and improved access to HIV education, prevention, testing, and treatment services. While progress have been made in the areas of prevention, care, and treatment, HIV/AIDS continues to disproportionately impact Black and African American individuals. This day raises awareness of the continued work that is needed to improve access to prevention and care and reduce health disparities related to HIV. Use the hashtag on social media to learn more and honor the day.

Read more here: https://www.med.unc.edu/cfar/2026/02/the-unc-cfar-honors-national-black-hiv-aids-awareness-day/

01/29/2026

The Respond Carolinas project is working to strengthen HIV prevention and care in Charlotte, NC and the surrounding area through implementing an enhanced version of the CDC's Social Network Strategy! The project is led by Ann Dennis, MD, MS, the principal investigator and an associate professor of infectious diseases at UNC; Meagan Zarwell, PhD, the co‑investigator and an associate professor of epidemiology and community health at UNC Charlotte; and other experts at UNC and UNCC. Read more here: https://www.med.unc.edu/cfar/2026/01/respond-carolinas-is-strengthening-hiv-prevention-and-care/

01/22/2026

A new study, published in Annals of Internal Medicine and led by Joe Eron, MD, Director of the CFAR Clinical Core, found that a new once-weekly oral HIV treatment regimen of islatravir plus lenacapavir (ISL + LEN) achieved virologic suppression through 48 weeks. These findings suggest that a once-weekly oral HIV treatment regimen could help reduce barriers associated with adhering to a daily pill for people living with HIV. Dr. Joe Eron discussed, “People living with HIV deserve options that work not only medically, but practically. Daily pills are effective, but they’re not the right fit for everyone. Seeing such strong suppression with a once‑weekly regimen is incredibly encouraging. It suggests we may be able to offer patients a simpler approach that still delivers the control they need.”

Read more here: https://www.med.unc.edu/cfar/2026/01/new-once-weekly-hiv-oral-regimen-shows-strong-results-after-48-weeks/

01/15/2026

The AIDS Clinical Trials Group (ACTG) has begun the IPACE-HIV study (Improving Physical Ability and Cellular Senescence Elimination in HIV). IPACE-HIV aims to evaluate the safety, tolerability, and efficacy of dasatinib and quercetin, medications that can help with reversing symptoms of frailty, in people living with HIV (PLWH), as well as their impact on physical function outcomes.

As Dr. Eron at UNC discussed, “ACTG is excited to undertake the first carefully controlled study evaluating senolytics as a potential intervention against frailty among people living with HIV. This approach is exciting because it focuses on altering what may be the underlying cause of age-related conditions instead of the conditions themselves.” Read more here: https://www.med.unc.edu/cfar/2026/01/actg-launches-ipace-hiv-to-study-frailty-intervention/

01/08/2026

UNC CFAR SBIS Core Director Vivian Go and Developmental Core Co-Director Bill Miller, along with their research team, recently published the findings from their implementation trial in ten provinces in Vietnam. The study aimed to compare two approaches to implementing the SNaP intervention: a “one-size-fits-all” approach and a tailored approach.

The results showed that using a tailored and locally informed approach to implement SNaP increased fidelity, compared to the “one-size-fits-all” method. Additionally, individuals who received the tailored SNaP approach had greater levels of viral suppression than those who received the standard version. Among both approaches, almost all participants initiated ART. These findings highlight the importance of using locally informed strategies when implementing evidence-based interventions related to HIV care and prevention for individuals who inject drugs.

Read more here: https://tinyurl.com/4bbavctr and https://www.med.unc.edu/cfar/2026/01/landmark-findings-from-study-on-a-tailored-implementation-approach-improves-hiv-intervention-for-people-who-inject-drugs-in-vietnam/

12/18/2025

Congratulations to the UNC Institute for Global Health and Infectious Diseases for being awarded an ID STEP (Infectious Disease Structured Training and Engagement Program) grant! This grant will be used to develop a program for medical students to expand equitable access to infectious disease expertise for folks living in North Carolina, particularly in rural and underserved areas. The program will be led by Jessica Lin, MD, MSCR, and Brian Bramson, MD, and supported by Sarah Rutstein, MD, PhD and Christopher Sellers, MD, MPH. Read more here: https://www.med.unc.edu/cfar/2025/12/id-step-grant-award-will-build-north-carolinas-pipeline-of-infectious-disease-specialists/

Address

Chapel Hill, NC
27599

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+19199661558

Website

http://unccfar.org/

Alerts

Be the first to know and let us send you an email when UNC Center for AIDS Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to UNC Center for AIDS Research:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Chapel Hill?